• 1
    Fishbein TM, Florman S, Gondolesi G et al. Intestinal transplantation before and after introduction of sirolimus. Transplantation 2002; 73: 15381542.
  • 2
    Abu-Elmagd K, Reyes J, Bond G et al. Clinical Intestinal Transplantation: a decade of experience at a single centre. Ann Surg 2001; 234: 404417.
  • 3
    Sudan DL, Kaufman SS, Shaw BW Jr et al. Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol 2000; 95: 15061515.
    Direct Link:
  • 4
    Caplan M, Jilling T. New concepts in necrotizing enterocolitis. Curr Opin Pediatr 2001; 13: 111115.
  • 5
    Moss TJ, Adler R. Necrotizing enterocolitis in older infants, children and adolescents. J Pediatr 1982; 100: 764766.
  • 6
    Khan FA, Kato T, Berho M et al. Graft failure secondary to necrotizing enterocolitis in multi-visceral transplantation recipients: Two case reports. Pediatr Transplantation 2000; 4: 215220.
  • 7
    Kamitsuka MD, Horton MK, Williams MA. The incidence of necrotizing enterocolitis after introducing standardized feeding schedules for infants between 1250 and 2500 grams and less than 35 weeks of gestation. Pediatrics 2000; 105: 379384.
  • 8
    Rayyis SF, Ambalavanan N, Wright L et al. Randomized trial of slow versus fast feed advancements on the incidence of necrotizing enterocolitis in very low birth weight infants. J Pediatr 1999; 134: 293297.
  • 9
    Gewolb IH, Schwalbe RS, Taciak VL et al. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1999; 80: 167173.
  • 10
    Nanthakumar NN, Fusunyan RD, Sanderson I et al. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 2000; 97: 60436048.
  • 11
    Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro-and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999; 103: 766771.
  • 12
    MacKendrick W, Caplan M, Hsueh W. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. Pediatr Res 1993; 34: 222228.
  • 13
    Tan XD, Chen YH, Liu QP et al. Prostanoids mediate the protective effect of trefoil factor 3 in oxidant-induced intestinal epithelial cell injury: role of cyclooxygenase-2. J Cell Sci 2000; 113: 21492155.
  • 14
    Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 1994; 94: 376383.
  • 15
    Caplan MS, Miller-Catchpole R, Kaup S et al. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 1999; 117: 577583.
  • 16
    Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999; 3: 197202.
  • 17
    Müller AR, Platz KP, Schirmeier A et al. 1-arginine application improves graft morphology and mucosal barrier function after small bowel transplantation. Transplant Proc 2000; 32: 12751277.
  • 18
    Rayes N, Seehofer D, Hansen S et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002; 74: 123127.